Brain Cancer — Trials, FDA Actions & Pivotal Research
11 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Brain Cancer.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Brain Cancer trials
Recruiting trials by city
Cities where Brain Cancer trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedPembrolizumab Glioblastoma Trial Reports Median PFS of 10.7 Months· Mar 25, 2026· drug: Pembrolizumab
2025
- Results postedBrain Cancer: Computer Training Program Compliance Results Posted· Dec 5, 2025
- Results postedNivolumab in IDH-Mutant Gliomas: Lower 6-Month PFS in Hypermutated Phenotype· Nov 24, 2025· drug: Nivolumab
- Results postedPembrolizumab/Lenvatinib Combo Shows Up to 77.4% DCR in Ovarian Cancer· Nov 17, 2025· drug: Pembrolizumab
- Results postedBrain Cancer: eSNAP + Caregiver Navigator Trial Results Posted· Oct 14, 2025
- Results postedPembrolizumab Glioblastoma Trial Identifies Vorinostat MTD in Combination· Oct 6, 2025· drug: Pembrolizumab
- Results postedPembrolizumab: Ferumoxytol MRI shows 58.3% specificity for glioblastoma response· Sep 9, 2025· drug: Pembrolizumab
- Results postedProton Beam Radiotherapy for Medulloblastoma & Pineoblastoma Results Posted· Aug 13, 2025
- Results postedNivolumab Glioblastoma Trial: Adverse Events Reported in Phase 1 Study· Aug 12, 2025· drug: Nivolumab
- Primary completionTofacitinib Trial in Recurrent Glioblastoma Reaches Primary Completion· Jun 16, 2025· drug: Tofacitinib
- Results postedProton Radiotherapy for Pediatric Brain Tumors Shows Favorable Disease Control· Jun 3, 2025